Flot.bio’s Post

Flot.bio reposted this

View profile for Philip Hemme, graphic

Founder & CEO @ Flot.bio

Here’s a teaser to the first open-air episode from San Sebastián 🇪🇸 with Naveed Siddiqi of one of the world’s largest biotech investors (Novo Holdings). Discover what things are really like in European biotech at the moment. “Multiple billion $ companies and multiple billion $ exits, we need more of that in Europe, and that needs scale capital.” We also talked about his upbringing as a second-generation immigrant in the UK and the importance of diversity. I’ve known him since he was a partner at Andera. He is a sharp investor, but also very friendly and open. You can now watch (or listen) to the full episode for free on YouTube (link in the comments), Spotify or Apple. What do you think? 🤔

Philip Hemme

Founder & CEO @ Flot.bio

3mo

Another success for Novo Holdings from yesterday, with Zurich-based Numab selling one of its antibody programs to J&J for $1.25B cash. Novo co-led the $100M series C in May 2021, via a colleague of Naveed 🎉

Like
Reply
Nana Bit-Avragim (she/her)

Creating & Building New Market in Healthcare & Biotech

3mo

Really exciting time for #biotech investment. Thanks for your tough and relevant questions, Philip! Love to see Naveed Siddiqi at the upcoming Frontiers Health conference in #Berlin this October! The wonderful team behind the conference is cooking super exciting program on trends and latest achievements in biotech and #synbio. I‘m sure, Elena Pirofalo and Luigi Pavia would love to get in touch with Naveed to highlight the journey of Novo Holdings. Cc: Kristin Milburn

See more comments

To view or add a comment, sign in

Explore topics